Evidence map›Paper›PMID 27793595›Full record

ArticleImmunity2016

Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand.

Michelle L Ols, Jaime L Cullen, Adriana Turqueti-Neves, Josephine Giles, Mark J Shlomchik

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. IgDAging cell · 2022
    Article
  5. Targeting TNature immunology · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Bioactive Constituents ofMolecules (Basel, Switzerland) · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. An update on lupus animal models.Current opinion in rheumatology · 2017
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michelle L OlsDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06519, USA.
Jaime L CullenDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06519, USA.
Adriana Turqueti-NevesDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Josephine GilesDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Mark J ShlomchikDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Electronic address: mshlomch@pitt.edu.
Yale University · USUniversity of Pittsburgh · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, WARREN D · 2007 to 2017
$7.0M
THE ROLE OF B CELLS IN LUPUS NEPHRITIS AND VASCULITISR01AR044077 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, MARK J · 1997 to 2016
$6.2M
Activation and regulation of autoreactive B cells in health and diseaseR01AI073722 · NIAID · YALE UNIVERSITY · PI SHLOMCHIK, MARK J · 2008 to 2012
$2.6M
LSRII Flow Cytometric AnalyzerS10RR023431 · NCRR · YALE UNIVERSITY · PI SHLOMCHIK, MARK J · 2007 to 2007
$339k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016359NCRR NIH HHS S10 RR023431NIAID NIH HHS R01 AI073722NIAID NIH HHS T32 AI007019NIAMS NIH HHS P30 AR053495NIAMS NIH HHS R01 AR044077
6 · The paper itself

Abstract

The extrafollicular (EF) plasmablast response to self-antigens that contain Toll-like receptor (TLR) ligands is prominent in murine lupus models and some bacterial infections, but the inhibitors and activators involved have not been fully delineated. Here, we used two conventional dendritic cell (cDC) depletion systems to investigate the role of cDCs on a classical TLR-dependent autoreactive EF response elicited in rheumatoid-factor B cells by DNA-containing immune complexes. Contrary to our hypothesis, cDC depletion amplified rather than dampened the EF response in Fas-intact but not Fas-deficient mice. Further, we demonstrated that cDC-dependent regulation requires Fas and Fas ligand (FasL) expression by T cells, but not Fas expression by B cells. Thus, cDCs activate FasL-expressing T cells that regulate Fas-expressing extrafollicular helper T (Tefh) cells. These studies reveal a regulatory role for cDCs in B cell plasmablast responses and provide a mechanistic explanation for the excess autoantibody production observed in Fas deficiency.

Indexed as

AnimalsAutoantibodiesAutoimmunityB-LymphocytesCell SeparationDendritic CellsDisease Models, AnimalEnzyme-Linked Immunospot AssayFas Ligand Proteinfas ReceptorFlow CytometryFluorescent Antibody TechniqueLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred MRL lprAutoantibodiesFas Ligand Proteinfas Receptor

Identifiers

PMID27793595
PMCPMC5112117
OpenAlexW2533886375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.